dr. hamid on the progression of therapy for metastatic prostate cancer
Published 4 years ago • 126 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:23
dr. hamid on the evolution of precision medicine in prostate cancer
-
1:31
dr. hamid on the exploration of predictive biomarkers in mhspc subtypes
-
6:16
evolution of treatment for metastatic castration-resistant prostate cancer
-
0:53
dr. freedland on real-world utility of enzalutamide in prostate cancer
-
0:51
dr. dicker on the impact of genetic testing for prostate cancer
-
1:22
dr. hwang on the state of treatment in metastatic prostate cancer
-
1:13
dr. yu on combination therapy for patients with metastatic prostate cancer
-
8:28
metastatic prostate cancer: androgen receptor biology
-
2:03
dr. grivas on the role of targeted therapy in prostate cancer
-
0:52
dr. susan slovin summarizes the evolution of prostate cancer immunotherapies
-
1:03
dr. zhang on the arches trial in prostate cancer
-
1:03
dr. hwang on the evolution of treatment in metastatic cspc
-
1:16
dr. hamstra on length of radiation treatments for patients with prostate cancer
-
1:27
dr. zhang discusses the impact of the stampede trial in prostate cancer
-
1:14
dr. kearns on choosing treatment for patients with prostate cancer
-
0:48
dr. kantoff on evolving role of docetaxel in prostate cancer treatment
-
2:46
dr. sweeney on the phase iii enzamet trial in metastatic hormone-sensitive prostate cancer
-
5:22
standard of care in metastatic prostate cancer
-
1:17
dr. hamid on a potential biomarker of response to docetaxel in mhspc